Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Anteris Technologies Global Corp. (AVR) vs STAAR Surgical Company (STAA)

Anteris Technologies Global Corp. and STAAR Surgical Company are both Medical Instruments & Supplies companies. STAAR Surgical Company is the larger, with a market value of $991.9M against $745.6M — 1.3× the size. Anteris Technologies Global Corp. has negative trailing earnings, so its P/E is not meaningful; STAAR Surgical Company trades at 293×. STAAR Surgical Company grew revenue faster over the last twelve months: 51.3% against −9.56%. STAAR Surgical Company has the higher net margin (1.13% vs −4,619.3%) and the higher return on invested capital (4.67% vs 0.00%). Across the 17 metrics below, STAAR Surgical Company leads on 14 and Anteris Technologies Global Corp. on 3.

Valuation

Metric AVR STAA Medical Instruments & Supplies median
P/E n/m 293.00 34.17
P/S 333.87 3.04 2.83
P/B 2.97 2.82 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m 38.03 16.08
EV/Sales 219.27 2.60 3.06
Earnings yield (25.36%) 0.34% (1.84%)
Free cash flow yield (11.79%) (0.66%) 0.17%

Profitability

Metric AVR STAA Medical Instruments & Supplies median
Gross margin 74.98% 76.62% 54.62%
Operating margin (4,738.36%) 4.04% 1.64%
Net margin (4,619.27%) 1.13% 0.00%
Free cash flow margin (3,937.07%) (1.99%) 1.61%
Return on equity (75.13%) 1.09% 0.00%
Return on assets (66.31%) 0.84% 0.00%
Return on invested capital 0.00% 4.67% 0.00%

Growth

Metric AVR STAA Medical Instruments & Supplies median
Revenue growth (TTM) (9.56%) 51.30% 9.20%
EPS growth (last fiscal year) 30.71% (295.12%) —
Revenue growth, 5-year CAGR — 7.93% 9.48%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AVR STAA Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.08
Current ratio 14.20 4.66 2.49
Net debt to EBITDA 0.14 2.25 0.83

Dividend

Metric AVR STAA Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio — 0.00 0.00

Size

Metric AVR STAA Medical Instruments & Supplies median
Market cap 745.56m 991.85m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack